The phospho-ERK1/2 levels are reduced in PCOS granulosa cells [22], whereas the MAPK/ERK signaling pathway is hyperactive in the PCOS endometrium [23]. The gene discussed is MAPK1; the disease is polycystic ovary syndrome.